Retroviridae Proteins, Oncogenic
"Retroviridae Proteins, Oncogenic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Retroviral proteins that have the ability to transform cells. They can induce sarcomas, leukemias, lymphomas, and mammary carcinomas. Not all retroviral proteins are oncogenic.
| Descriptor ID |
D015682
|
| MeSH Number(s) |
D12.776.624.664.520.750 D12.776.964.700.750 D12.776.964.775.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Retroviridae Proteins, Oncogenic".
Below are MeSH descriptors whose meaning is more specific than "Retroviridae Proteins, Oncogenic".
This graph shows the total number of publications written about "Retroviridae Proteins, Oncogenic" by people in this website by year, and whether "Retroviridae Proteins, Oncogenic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Retroviridae Proteins, Oncogenic" by people in Profiles.
-
Liu A, Prendergast GC. Geranylgeranylated RhoB is sufficient to mediate tissue-specific suppression of Akt kinase activity by farnesyltransferase inhibitors. FEBS Lett. 2000 Sep 22; 481(3):205-8.
-
Prendergast GC. Myc and Myb: are the veils beginning to lift? Oncogene. 1999 May 13; 18(19):2914-5.
-
Kubota S, Pomerantz RJ. A cis-acting peptide signal in human immunodeficiency virus type I Rev which inhibits nuclear entry of small proteins. Oncogene. 1998 Apr 09; 16(14):1851-61.
-
Kubota S, Hatanaka M, Pomerantz RJ. Nucleo-cytoplasmic redistribution of the HTLV-I Rex protein: alterations by coexpression of the HTLV-I p21x protein. Virology. 1996 Jun 15; 220(2):502-7.
-
Feinman R, Qiu WQ, Pearse RN, Nikolajczyk BS, Sen R, Sheffery M, Ravetch JV. PU.1 and an HLH family member contribute to the myeloid-specific transcription of the Fc gamma RIIIA promoter. EMBO J. 1994 Aug 15; 13(16):3852-60.
-
Prendergast GC, Davide JP, deSolms SJ, Giuliani EA, Graham SL, Gibbs JB, Oliff A, Kohl NE. Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton. Mol Cell Biol. 1994 Jun; 14(6):4193-202.